Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Malignant mesenchymoma with widespread metastasis including bone marrow involvement in a dog.

Weishaar KM, Edmondson EF, Thamm DH, Olver CS.

Vet Clin Pathol. 2014 Jul 30. doi: 10.1111/vcp.12180. [Epub ahead of print]

PMID:
25132008
[PubMed - as supplied by publisher]
2.

Serum 25-hydroxyvitamin D concentrations in dogs - correlation with health and cancer risk.

Selting KA, Sharp CR, Ringold R, Thamm DH, Backus R.

Vet Comp Oncol. 2014 Jul 8. doi: 10.1111/vco.12101. [Epub ahead of print]

PMID:
25041357
[PubMed - as supplied by publisher]
3.

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma.

Barnard RA, Wittenburg LA, Amaravadi RK, Gustafson DL, Thorburn A, Thamm DH.

Autophagy. 2014 Aug 1;10(8):1415-25. doi: 10.4161/auto.29165. Epub 2014 May 20.

PMID:
24991836
[PubMed - in process]
4.

Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma.

Shoeneman JK, Ehrhart EJ 3rd, Charles JB, Thamm DH.

Vet Comp Oncol. 2014 Jun 13. doi: 10.1111/vco.12104. [Epub ahead of print]

PMID:
24923332
[PubMed - as supplied by publisher]
5.

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor.

Halsey CH, Gustafson DL, Rose BJ, Wolf-Ringwall A, Burnett RC, Duval DL, Avery AC, Thamm DH.

BMC Vet Res. 2014 May 6;10:105. doi: 10.1186/1746-6148-10-105.

PMID:
24885200
[PubMed - in process]
Free PMC Article
6.

Autophagy and cancer therapy.

Thorburn A, Thamm DH, Gustafson DL.

Mol Pharmacol. 2014 Jun;85(6):830-8. doi: 10.1124/mol.114.091850. Epub 2014 Feb 26. Review.

PMID:
24574520
[PubMed - indexed for MEDLINE]
7.

Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.

Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE.

J Vet Intern Med. 2014 Mar-Apr;28(2):554-63. doi: 10.1111/jvim.12313. Epub 2014 Feb 10.

PMID:
24512451
[PubMed - in process]
8.

GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma.

Thamm DH, Vail DM, Kurzman ID, Babusis D, Ray AS, Sousa-Powers N, Tumas DB.

BMC Vet Res. 2014 Jan 25;10:30. doi: 10.1186/1746-6148-10-30.

PMID:
24460928
[PubMed - in process]
Free PMC Article
9.

Vinorelbine rescue therapy for dogs with primary urinary bladder carcinoma.

Kaye ME, Thamm DH, Weishaar K, Lawrence JA.

Vet Comp Oncol. 2013 Aug 25. doi: 10.1111/vco.12065. [Epub ahead of print]

PMID:
23981116
[PubMed - as supplied by publisher]
10.

DNA repair deficiency as a susceptibility marker for spontaneous lymphoma in golden retriever dogs: a case-control study.

Thamm DH, Grunerud KK, Rose BJ, Vail DM, Bailey SM.

PLoS One. 2013 Jul 23;8(7):e69192. doi: 10.1371/journal.pone.0069192. Print 2013.

PMID:
23935952
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.

Dailey DD, Anfinsen KP, Pfaff LE, Ehrhart E, Charles JB, Bønsdorff TB, Thamm DH, Powers BE, Jonasdottir TJ, Duval DL.

BMC Vet Res. 2013 Jul 1;9(1):130. doi: 10.1186/1746-6148-9-130.

PMID:
23816051
[PubMed - in process]
Free PMC Article
12.

Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell lines.

Lawrence JA, Huelsmeyer MK, Thamm DH, Tumas DB, Birkus G, Kurzman I, Vail DM.

Vet Comp Oncol. 2013 May 15. doi: 10.1111/vco.12038. [Epub ahead of print]

PMID:
23672437
[PubMed - as supplied by publisher]
13.

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.

Nguyen SM, Thamm DH, Vail DM, London CA.

Vet Comp Oncol. 2013 Mar 28. doi: 10.1111/vco.12032. [Epub ahead of print]

PMID:
23534501
[PubMed - as supplied by publisher]
14.

Immunohistochemical characterization of feline oral squamous cell carcinoma.

Yoshikawa H, Ehrhart EJ, Charles JB, Thamm DH, Larue SM.

Am J Vet Res. 2012 Nov;73(11):1801-6. doi: 10.2460/ajvr.73.11.1801.

PMID:
23106467
[PubMed - indexed for MEDLINE]
15.

Genomic instability and telomere fusion of canine osteosarcoma cells.

Maeda J, Yurkon CR, Fujisawa H, Kaneko M, Genet SC, Roybal EJ, Rota GW, Saffer ER, Rose BJ, Hanneman WH, Thamm DH, Kato TA.

PLoS One. 2012;7(8):e43355. doi: 10.1371/journal.pone.0043355. Epub 2012 Aug 16.

PMID:
22916246
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Tyrosine kinase inhibitor special issue.

Thamm DH.

Vet Comp Oncol. 2012 Sep;10(3):161-2. doi: 10.1111/j.1476-5829.2012.00339.x. No abstract available.

PMID:
22882484
[PubMed - indexed for MEDLINE]
17.

An asymmetric synthesis of 1,2,4-trioxane anticancer agents via desymmetrization of peroxyquinols through a Brønsted acid catalysis cascade.

Rubush DM, Morges MA, Rose BJ, Thamm DH, Rovis T.

J Am Chem Soc. 2012 Aug 22;134(33):13554-7. doi: 10.1021/ja3052427. Epub 2012 Aug 7.

PMID:
22871165
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Development of a limited-sampling model for prediction of doxorubicin exposure in dogs.

Wittenburg LA, Thamm DH, Gustafson DL.

Vet Comp Oncol. 2014 Jun;12(2):114-9. doi: 10.1111/j.1476-5829.2012.00340.x. Epub 2012 Jul 3.

PMID:
22747489
[PubMed - in process]
Free PMC Article
19.

Diagnostic accuracy of pre-treatment biopsy for grading soft tissue sarcomas in dogs.

Perry JA, Culp WT, Dailey DD, Eickhoff JC, Kamstock DA, Thamm DH.

Vet Comp Oncol. 2014 Jun;12(2):106-13. doi: 10.1111/j.1476-5829.2012.00333.x. Epub 2012 May 22.

PMID:
22617002
[PubMed - in process]
20.

Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.

Burton JH, Garrett-Mayer E, Thamm DH.

Vet Comp Oncol. 2013 Dec;11(4):306-15. doi: 10.1111/j.1476-5829.2012.00324.x. Epub 2012 May 2.

PMID:
22548975
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk